|
Summary Information: Adaptimmune Therapeutics plc American Depositary Shares NASDAQ:ADAP |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for people with cancer. The Company's unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors.
__The following are links to various summary and news pages for __Adaptimmune Therapeutics plc American Depositary Shares [ ADAP ]. __Note: Some Links might not have information for the company. |
|